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Abstract Elimination of pathogens is the basis of host
resistance to infections; however, relationship between
persisting pathogens and disease has not been clarified.
Leishmania major infection in mice is an important model
of host–pathogen relationship. Infected BALB/c mice
exhibit high parasite numbers in lymph nodes and spleens,
and a chronic disease with skin lesions, splenomegaly, and
hepatomegaly, increased serum IgE levels and cytokine
imbalance. Although numerous gene loci affecting these
disease symptoms have been reported, genes controlling
parasites’ elimination or dissemination have never been
mapped. We therefore compared genetics of the clinical and
immunologic symptomatology with parasite load in
(BALB/c×CcS-11) F2 hybrids and mapped five loci, two
of which control parasite elimination or dissemination.
Lmr5 influences parasite loads in spleens (and skin lesions,
splenomegaly, and serum IgE, IL-4, and IFNγ levels), and
Lmr20 determines parasite numbers in draining lymph
nodes (and serum levels of IgE and IFNγ), but no skin or
visceral pathology. Three additional loci do not affect
parasite numbers but influence significantly the disease
phenotype—Lmr21: skin lesions and IFNγ levels, Lmr22:
IL-4 levels, Lmr23: IFNγ levels, indicating that develop-
ment of L. major-caused disease includes critical regula-
tions additional to control of parasite spread.
Keywords Leishmania major.Mouse.Geneticsofparasite
elimination.Susceptibilitytoleishmaniasis.
Functionalheterogeneity
Parasite infection induces in the host both the responses that
limit parasite growth and multiplication and responses that
are either neutral or can lead to damage of host’s tissues.
Interaction between the infecting parasite and the host’s
immune system is especially important for understanding of
pathogenesis of diseases caused by chronic infections.
One of the important unresolved questions in pathogen-
esis of chronic infections is the relationship between the
pathogen load and clinical symptoms. Whereas early
elimination of infectious agents generally precludes devel-
opment of chronic disease, the relationship between load
and spread of persisting pathogens and manifestations and
course of ensuing disease has not been clarified. Although
the number of studies addressing this problem is limited,
they provided examples of unexpected genetic and func-
tional complexity in infections with various pathogens such
as Borrelia burgdorferi (Ma et al. 1998), Toxoplasma
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DOI 10.1007/s00251-009-0392-9gondii (Johnson et al. 2002), and Trypanosoma cruzi
(Marinho et al. 2004). This involved strain differences in
both the relationship between pathogen load and intensity
of symptoms of disease and in dissemination to different
organs. However, the relationship between genetic control
of parasite load and parasite-induced pathology has never
been analyzed simultaneously in segregating populations
(Råberg et al. 2007).
Leishmania infection in mice has served as a paradigm
of interaction of pathogen and host. Leishmania parasites
are transmitted to vertebrate hosts by infected phlebotomine
sandflies and infect professional phagocytes (macrophages,
monocytes, and neutrophils) as well as dendritic cells and
fibroblasts. The major host cell is macrophage, in which
parasites multiply, eventually rupturing the cell and
spreading to uninfected cells. They affect skin, mucous
membranes, lymph nodes, spleen, bone marrow, liver,
lungs, and, in rare cases, even the brain. The expansion of
the parasites is determined by multiple factors, including
both parasite characteristics (reviewed in McMahon-Pratt
and Alexander 2004) and host genetics (reviewed in
Lipoldová and Demant 2006). Leishmania parasites can
evade the first-line defense systems, inhibit several func-
tions of host’s immune cells (Olivier et al. 2005), and prime
the development of an immune state favorable for the
parasite. In the mouse model, distinct clinical manifestation
of cutaneous and visceral leishmaniasis observed in humans
can be reproduced in some mouse strains. Mice from
several strains (BALB/c, SWR/J, P/J) develop severe
systemic disease affecting skin and visceral organs (Sacks
and Noben-Trauth 2002), whereas mice of the majority of
inbred strains (e.g., C3H, CBA, C57BL/6, B10.D2, 129/Sv,
and STS/A) after infection with L. major develop no
pathological changes or only small spontaneously healing
cutaneous lesions restricted to the infection site. The wide
spectrum of clinical symptoms and immunological reac-
tions in susceptible strains provides an opportunity to
define control of individual components of disease pheno-
type. However, there are no data about the relationship of
parasite load to manifestations of disease.
As the non-healer phenotype of BALB/c mice is
controlled by multiple genes, we used a special tool for
genetic analysis of multigenic traits, the recombinant
congenic (RC) strains. Each of the 20 CcS/Dem RC
mouse strains carries a different random subset of 12.5%
genes of the resistant donor strain STS/A (STS) on the
background of the susceptible strain BALB/cHeA
(BALB/c). As a consequence, the individual STS genes
contributing to the resistance to infection L. major were
distributed among different RC strains. Previously, we
studied three CcS/Dem strains: the most resistant strain
CcS-5, the strain CcS-20 that exhibits intermediate
susceptibility, and the susceptible strain CcS-16. This
resulted in mapping of 17 loci, Lmr3–Lmr19 (Leishmania
major response 3–19), which are associated with 13
different combinations of pathological symptoms and
immunological reactions (Lipoldová et al. 2000; Badalová
et al. 2002;V l a d i m i r o ve ta l .2003; Havelková et al.
2006).
In the present study, in addition to the disease symptoms
and immunological parameters, we also measured load of
parasites in draining lymph nodes and spleen. This allowed
us to analyze for the first time the genetic relationship
between the presence of parasites and manifestations of
disease. We mapped genes controlling these parameters in
the strain CcS-11, which after infection presents smaller
skin lesions, lower splenomegaly and hepatomegaly, fewer
parasites in spleen, and lower concentrations of IgE and IL-
4 in serum than the susceptible strain BALB/c (Lipoldová
et al. 2002 and this paper). We show here that the degree of
elimination of parasites is genetically controlled and that
this control is organ specific. Different genes control
parasite load predominantly in lymph nodes or in spleen.
Moreover, we show that additional genes that do not affect
parasites’ presence in these two organs also significantly
affect the course of disease.
Materials and methods
Mice Males and females of strains BALB/c and CcS-11
were 8 to 24 weeks old at the time of infection. When used
for these experiments, strain CcS-11 was in more than 38
generations of inbreeding. The parts of its genome inherited
from the BALB/c or STS parents were defined (Stassen et
al. 1996). Two hundred and ninety-nine F2 hybrids between
CcS-11 and BALB/c (age 9 to 13 weeks at the time of
infection, mean age 11 weeks, median 12 weeks) were
produced at the Institute of Molecular Genetics. They
comprised 155 females and 144 males. During the
experiment, male and female mice were placed into
separate rooms and males were caged individually. They
were tested in three successive experimental groups. The
research had complied with all relevant European Union
guidelines for work with animals.
Parasites Leishmania major LV 561 (MHOM/IL/67/LRC-
L137 JERICHO II) was maintained in rump lesions of
BALB/c females. Amastigotes were transformed to pro-
mastigotes using SNB-9 (Diamond and Herman 1954).
Promastigotes (10
7) from 6-day-old subculture 2 were
inoculated in 50 μl sterile saline s.c. into mouse rump.
Disease phenotype The size of the primary skin lesions was
measured weekly using a Vernier caliper gauge. The mice
were killed 8 weeks after infection. Blood, spleen, liver,
620 Immunogenetics (2009) 61:619–633and inguinal lymph nodes were collected for further
analysis.
Quantification of parasite load in spleens and inguinal
lymph nodes by PCR–ELISA Total DNA from spleens and
inguinal lymph nodes was prepared using a standard
proteinase procedure. To detect Leishmania DNA by
PCR, two primers (digoxigenin-labeled F 5′-ATT TTA
CAC CAA CCC CCA GTT-3′ and biotin-labeled R 5′-GTG
GGG AGG GGG CGT TCT-3′; Rodgers et al. 1990; VBC-
GENOMICS Biosciences Research, Vienna, Austria) were
used for amplification of the 120-bp conservative region of
the minicircle kinetoplast of Leishmania parasites. Briefly,
50 ng of extracted DNA with 5 pmol of each kinetoplast
primer, 0.5 mM concentration of each dNTP, 2 mM MgCl2,
50 mM KCl, 10 mM Tris–HCl (pH 8.3), and 2 U of Taq
polymerase (Invitrogen Brazil Ltda., São Paulo, Brazil) was
amplified in a total volume of PCR reaction of 20 μl. As a
positive control, we used 20 ng of L. major DNA per
reaction (0.3 fg of L. major DNA approximately corre-
sponds to one parasite). After an initial hot start at 94°C for
90 s, the conditions used for amplification were: 94°C for
30 s, 53°C for 45 s, 72°C for 60 s (26 cycles for DNA from
l y m p hn o d e sa n d3 3c y c l e sf o rD N Af r o ms p l e e n s ) ,
followed by the final extension 72°C for 10 min, using
the I-Cycler (Bio-Rad Laboratories, Hercules, CA, USA).
Concentration of the amplified 120-bp region of Leishman-
ia DNA in PCR product was determined using the modified
ELISA protocol (Pharmingen, San Diego, CA, USA).
Plates were coated with 100 μl per well streptavidin
solution (0.5 μg/ml in 0.1 M NaHCO3 pH 7.0) at 4°C
overnight. PCR samples were diluted to 2% concentration
in 2% FCS/PBS. The positive PCR control was used as a
standard for ELISA. Plates were incubated at room
temperature for 2 h and then incubated at room temperature
for 45 min with the anti-digoxigenin detecting antibody,
Fab fragments (Roche Diagnostic GmbH, Mannheim,
Germany) 0.15 U/ml, diluted in 2% FCS/PBS. As a
substrate for color reaction development, we used 2,2′-
azino-bis(3-ethylbenzo-thiazoline-6-sulfonic acid) (ABTS)
solution (150 mg ABTS in 500 ml 0.1 M citric acid, pH
4.35) (Sigma-Aldrich Co., St. Louis, MO, USA) with
0.03% H2O2. The color reaction was stopped after 10 min
by adding 50 μl 0.5 M oxalic acid per well. The Leishmania
loads were determined using the ELISA Reader Tecan and
the curve fitter program KIM-E (Schoeller Pharma, Prague,
Czech Republic) using least squares-based linear regression
analysis.
Cytokine and IgE levels IFNγ, IL-4, IL-12, and IgE levels
in serum were determined using the primary and secondary
monoclonal antibodies (IFNγ=R4-6A2, XMG1.2; IL-4=
BVD4-1D11, BVD6-24G2; IL-12=Red-T and G297-298;
IgE=R35-72, R3592) and standards from Pharmingen, San
Diego, CA (recombinant mIFNγ,m I L - 4 ,m I L - 1 2p 7 0
heterodimer, and purified mIgE=C38-2). The ELISA
measurements of IFNγ, IL-4, IL-12, and IgE levels were
performed as described in the previous section.
Genotyping of F2 mice DNAwas isolated from tails using a
standard proteinase procedure. The strain CcS-11 differs
from BALB/c at STS-derived segments on eight chromo-
somes, respectively (Stassen et al. 1996). These differential
segments were typed in the F2 hybrid mice between CcS-11
and BALB/c using 16 microsatellite markers (Research
Genetics, Huntsville, FL, USA): D1Mit403, D3Mit45,
D7Mit54, D7Mit18, D7Nds1, D7Mit282, D7Mit67,
D7Mit259, D8Mit85, D10Mit12, D10Mit46, D12Mit37,
D16Mit73, D19Mit51, D19Mit60, and D19Mit46. The
maximal distance between any two markers in the
chromosomal segments derived from the strain STS or
from the nearest BALB/c derived markers was 19 cM.
The PCR genotyping of polymorphic simple sequence
length markers with fragment length difference of more
than 10 bp was performed using unlabeled primers
(D1Mit403, D7Mit18, D7Nds1, D7Mit282, D7Mit67,
D7Mit259, D10Mit12, D10Mit46, D12Mit37, D16Mit73,
D19Mit51, D19Mit60, and D19Mit46). DNAwas amplified
in a 20-µl PCR reaction with 0.11 μM of forward and
reverse primer, 0.2 mM concentration of each dNTP, 1.0–
3.0 mM MgCl2 (the optimal concentration for the most
p r i m e r sw a s1 . 5m M ) ,5 0m MK C l ,1 0m MT r i s –HCl (pH
8 . 3 ) ,0 . 5Uo fT a qp o l y m e r a s e( G I B C O ,G r a n dI s l a n d ,N Y ,
USA), and approximately 40 ng of tail DNA. PCR
reaction was performed using the I-Cycler (Bio-Rad
Laboratories), according to the following scheme: an
initial hot start 3 min at 94°C, followed by 40 cycles of
94°C for 30 s for denaturing, 55° for 60 s for annealing
(except markers D7Mit18 and D7Mit259, for which
optimal Ta=57°), 72° for 60 s for elongation, and finally
3 min at 72° for final extension. Each PCR product was
m i x e dw i t h5μl of loading buffer and electrophoresed in
2–3% agarose gel for 20 min to 1.5 h at 150 V. The PCR
genotyping for simple sequence length polymorphic
markers with fragment length difference of less than
10 bp (D3Mit45, D7Mit54, and D8Mit85) was performed
using [γ-
32P]ATP end-labeled primers as described else-
where (Krulová et al. 1997).
Statistical analysis The linkage of genes that control
parasite spread, organ pathology, and immune parameters
with microsatellite markers was examined with analysis of
variance (NCSS, Kaysville, UT, USA) and PROC GLM
statement of SAS 8.2 for Windows (SAS Institute, Gary,
NC, USA). Genotype, sex, and age were fixed factors and
the experiment was random factor. In order to obtain
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variables were transformed as shown in the legends of the
tables. We tested individual effects of all markers as well as
of all their pairwise combinations using the backward
elimination procedure (Tripodis et al. 2001). The pheno-
types of compound genotypes that significantly deviated
from simple additive effects of the alleles indicated
interactions. Markers and interactions with P <0.05 were
combined in a single comparison.
The time course of skin lesion development was
evaluated on the basis of weekly measurements of lesion
size in each mouse in weeks 4 to 8 after infection. Mixed
model of analysis of variance (Proc Mixed, SAS) with
marker as the fixed variable, the week of observation as the
covariate, and mouse as random variable have been used to
evaluate the linkage.
The percentage of variance explained by an independent
variable, the partial R
2, was computed in the standard way
by subtracting the regression sums of squares of the model
without the variable of interest (SS(β1, β2, β3, β4/β0)) from
the regression sums of squares of the full model (SS(β1, β2,
β3, β4, β5/β0)); this difference divided by the residual sums
of squares (RSS(β1, β2, β3, β4, β5/β0)) algebraically
expressed as
SS b1;b2;b3;b4=b0 ðÞ ðÞ   SS b1;b2;b3;b4;b5=b0 ðÞ ðÞ
RSS b1;b2;b3;b4;b5=b0 ðÞ
indicated the contribution of the independent variable.
To obtain genome-wide significance values (corrected P),
the observed P values (αT) were adjusted according to
Lander and Schork (1994) using the formula:
aT   C þ 2rGhðTÞ ½  aT
where G=1.75 M (the length of the segregating part of the
genome=12.5% of 14 M), C=8 (number of chromosomes
segregating in cross between CcS-11 and BALB/c, respec-
tively); ρ=1.5 for F2 hybrids; h(T)=the observed statistic (F
ratio). Direct comparisons of this method with permutation
analyses in establishing genome-wide significance thresh-
olds found them comparable (Singer et al. 2005).
Power computation for detection of sex difference in
marker effects on parasite load were carried forth. Across
genotypes (D1Mit403, D10Mit12), the sample size was
balanced between males (n=144) and females (n=144) for
D1Mit403 and males (n=143) and females (n=146) for
D10Mit12. The marker frequencies for each genotype
ranged for CC from 59 to 65, for CS from 149 to 157,
and for SS from 66 to 79. Under these sample sizes, we
were able to detect on the log scale at 0.80 power and α=
0.05 (two-sided) effect sizes for sex by marker interaction
in ranges from 0.75 to 0.86 standard deviation units or
larger, depending upon the specific differential effect.
Results
Differences in organ pathology and immune response
between strains CcS-11 and BALB/c The parasite load,
disease symptoms, and immunological parameters in
BALB/c and CcS-11 mice are given in Table 1. BALB/c
mice develop larger skin lesions during the course of
infection (weeks5, 6, 7, and 8) and larger splenomegaly and
hepatomegaly compared to the strain CcS-11, with no
significant sex difference in size of skin lesions, spleno-
megaly, and hepatomegaly (data not shown). Larger
numbers of parasites in spleen were also observed in strain
BALB/c, but there were no significant differences in
parasite load in draining lymph nodes. Parasite numbers
in spleens of strain CcS-11 and in draining lymph nodes of
both BALB/c and CcS-11 were significantly higher in
males (Table 1, Fig. 1). Serum IgE and IL-4 levels were
higher in strain BALB/c than in strain CcS-11, but there
were no strain differences in serum concentrations of IFNγ
and IL-12. Serum IgE and cytokine levels were not
influenced by sex (Table 1).
Loci that influence parasite burden, organ pathology, and
immunological parameters in the strain CcS-11 The sum-
mary of the detected loci and their phenotypic effects is
given in Table 2. Linkage analysis of F2 hybrids between
BALB/c and CcS-11 indicated four novel loci Lmr20,
Lmr21, Lmr22, and Lmr23 on chromosomes 1, 7, 12, and
16, respectively. For the previously detected locus Lmr5 on
chromosome 10 (Lipoldová et al. 2000), we detected an
additional effect on parasite load in spleen and on IL-4 level
in serum in interaction with Lmr22. These data are given in
Tables 3, 4, and 5 (single gene effects) and Tables 6, 7, and
8 (gene interactions).
These tables describing detected linkages give besides
the statistical significance of linkage also two other
quantitative characteristics (Lander and Botstein 1989) that
describe the size of their effect: (a) a magnitude of effect of
each locus that describes how large the phenotypic
difference is (e.g., in IgE level) between mice with different
alleles at this locus and (b) the explained variance (% of
variance) that is the proportion of phenotypic variation in
the tested population that is caused by the effects of these
alleles. The first parameter in our data varies between 1.4
and 2.5 (i.e., difference between the extreme phenotypes
caused by alleles at a locus is between 40% and 150%) and
the percent of explained variance 1–14. These value ranges
are common for majority of quantitative trait loci (QTLs) in
the mouse (Flint et al. 2005).
Parasite presence in secondary immune organs is con-
trolled by two loci, Lmr20 and Lmr5 (Table 3). Lmr20 on
chromosome 1 is linked to D1Mit403 and it controls
622 Immunogenetics (2009) 61:619–633parasite load in draining lymph nodes (corrected P=5.54×
10
−3). Its BALB/c allele is associated with higher parasite
numbers. The effects of Lmr20 account for 4.25% of
variance in parasite load in the lymph nodes. In addition,
there was a pronounced sex effect (P=10
−9) on parasite
numbers in draining lymph nodes and spleen. However,
there was no interaction between sex and the marker and no
sufficient power to establish whether the effects of Lmr20
are sex specific. This qualification concerns the effects of
the individual Lmr loci; the sex difference within the two
strains is highly significant (Table 1).
Lmr5 on chromosome 10 is linked to D10Mit12 and it
influences parasite load in spleens and splenomegaly
(corrected P=5.39×10
−3 and 6.98×10
−4, respectively).
The effects of Lmr5 account for 4.54% of variance in
parasite number in spleens and 11.60% of variance in
splenomegaly. Higher parasite numbers and a more severe
splenomegaly are associated with BALB/c allele. Separate
analysis of females and males revealed that Lmr5 deter-
mines parasite numbers in spleen and splenomegaly in
females (corrected P=5.76×10
−3 and 5.57×10
−4, respec-
tively). It accounts in females for 11.74% and 14.47% of
variance in parasite numbers and splenomegaly, respective-
ly, whereas differences in parasite numbers in spleens and
splenomegaly in males were not significant (Table 3).
However, absence of interaction between sex and marker
and power computations indicated that the present experi-
ments did not have sufficient power to establish whether
Lmr5 has a sex-specific effect. The present data are
compatible with additive effects of sex and genotype at
Lmr5.
Skin lesions are controlled by two loci: Lmr5 and Lmr21
(Table 4 and Fig. 2). Lmr5 on chromosome 10 is linked to
D10Mit12 and D10Mit46 (corrected P=5.27×10
−5 and
4.83×10
−5, respectively). Lmr21 on chromosome 7 is
linked to D7Mit67 and D7Mit282 (lesion size on week8;
corrected P=0.0116 and 0.0972). BALB/c allele of both
Lmr5 and Lmr21 is associated with larger lesions. The
impact of Lmr5 and Lmr21 on phenotype is higher in
Table 1 Comparison of immunopathological parameters in L. major infected mice of the strains BALB/c and CcS-11
Phenotype Strain P value
BALB/c CcS-11 Strain difference
Lesion size 5 weeks (mm
2) 60.79±6.33 (n=19) 29.55±6.33 (n=19) 1.34×10
−3
Lesion size 6 weeks (mm
2) 91.67±7.78 (n=19) 41.33±7.78 (n=19) 5.88×10
−5
Lesion size 7 weeks (mm
2) 107.42±9.52 (n=19) 46.54±9.52 (n=19) 6.91×10
−5
Lesion size 8 weeks (mm
2) 129.31±11.73 (n=19) 55.05±11.73 (n=19) 7.86×10
−5
Splenomegaly (spleen-to-body weight ratio×1,000) 17.84±1.13 (n=19) 12.26±1.13 (n=19) 1.51×10
−3
Hepatomegaly (liver-to-body weight ratio×1,000) 68.06±1.55 (n=19) 60.32±1.55 (n=19) 2.75×10
−3
IgE in serum (μg/ml) 10.22 3.54±0.29 (n=16) 3.97 1.62±0.28 (n=18) 6.79×10
−5
IFNγ in serum (ng/ml) 5.57 1.31±0.05 (n=18) 4.45 1.22±0.06 (n=14) 0.257
IL-12 in serum (ng/ml) 2.83 1.04±0.20 (n=16) 1.74 0.55±0.20 (n=15) 0.119
IL-4 in serum (ng/ml) 4.65 1.61±0.23 (n=12) 2.33 0.83±0.26 (n=9) 3.75×10
−2
Parasites in draining lymph nodes, total group
(arbitrary units)
1.61 5.08±0.20 (n=17) 2.30 5.44±0.19 (n=19) 0.211
Parasites in draining lymph nodes, females 0.57 4.04±0.23
a (n=9) 0.46 3.83±0.22
b (n=10) 0.643
Parasites in draining lymph nodes, males 9.28 6.83±0.37
a (n=8) 8.54 6.75±0.35
b (n=9) 0.931
Parasites in spleen, total group (arbitrary units) 1.58 5.06±0.29 (n=18) 0.31 3.43±0.28 (n=19) 4.02×10
−4
Parasites in spleen, females 1.10 4.70±0.45
c (n=8) 0.18 2.89±0.40
d (n=10) 8.36×10
−3
Parasites in spleen, males 3.08 5.73±0.34
c (n=10) 0.58 4.06±0.36
d (n=9) 6.01×10
−3
Means and standard errors of means and P values were computed by analysis of variance. Lesion size (mm
2), splenomegaly and hepatomegaly
(spleen and liver-to-body weight ratio×1,000, respectively) exhibited normal distribution without transformation. The following transformations
were used to obtain normal distribution: IgE levels in serum: IgE (μg/ml)—natural logarithm of value to the power of 1.5; IFNγ (ng/ml)—natural
logarithm of the value to the power of 0.5; IL-4 (ng/ml)—natural logarithm to the power of 1.1; IL-12 (ng/ml)—natural logarithm; parasite load
detected as parasite DNA content (arbitrary units) in spleen and in lymph nodes—natural logarithm of (value×100). Number of tested mice is
shown in brackets. The numbers in bold give the average non-transformed values.
aSex difference in BALB/c, P=9.26×10
−5
bSex difference in CcS-11, P=1.14×10
−5
cSex difference in BALB/c, P=0.133
dSex difference in CcS-11, P=8.93×10
−3
Immunogenetics (2009) 61:619–633 623Fig. 1 Parasites in hematoxylin–
eosin-stained inguinal lymph
node sections of female and male
mice. a Uninfected BALB/c
male, b L. major infected BALB/
cm a l e ,c uninfected BALB/c
female, d L. major infected
BALB/c female, e uninfected
CcS-11 male, f L. major infected
CcS-11 male, g uninfected CcS-
11 female, h L. major infected
CcS-11 female. Arrows show
groups of Leishmania parasites
(with a dark nucleus, smaller
kinetoplast, and light cytoplasm)
among normal lymph node cells
(b, d, f) and parasites inside a
macrophage (h)
624 Immunogenetics (2009) 61:619–633females than in males. In females, Lmr5 on chromosome 10
is linked with D10Mit12 and D10Mit46 (corrected P=
2.67×10
−4 and 7.28×10
−4, respectively), and Lmr21 on
chromosome 7 is linked with D7Mit67 (corrected P=
0.046). In males, we did not detect Lmr5 or Lmr21.
Components of the systemic immune response: Of the four
tested components (serum levels of IgE, IFNγ, IL-4, and
IL-12) we did not detect any linkage of IL-12 levels. The
linkages of the other three components involve five loci,
Lmr20, Lmr21, Lmr5, Lmr22 and Lmr23 (Table 5 single
gene effects and Tables 6, 7, and 8 gene interactions).
Serum IgE concentrations are influenced by Lmr20 and
Lmr5. Lmr20 on chromosome 1 is linked to D1Mit403
(corrected P=3.07×10
−3, 6.09% of variance) and its
BALB/c allele is associated with higher serum levels of
IgE. Influence of this locus on IgE level is observed only in
females (corrected P=1.81×10
−3, 11.76% of variance).
Lmr5 on chromosome 10 is linked to D10Mit12 (corrected
P value=3.02×10
−2, 4.70% of variance). When analyzed
separately, females and males exhibit allelic differences of
the same size and direction, but do not reach significant P
values due to insufficient number of mice in the separate
sexes.
Serum IFNγ concentrations are influenced by two
inter-locus interactions. Lmr20 marked by D1Mit403
interacts with Lmr23 linked to D16Mit73 (Table 6). The
highest level of IFNγ is observed in STS homozygotes in
both loci (corrected P=2.01×10
−2). This interaction
accounts for 6.93% of variance.
Serum IFNγ level is also controlled by the interaction of
Lmr21 (linked to D7Mit67) with Lmr5 (linked to
D10Mit12) (corrected P=1.95×10
−2, 7.18% of variance).
The lowest IFNγ levels are observed either in STS
homozygotes at both loci or in BALB/c homozygotes in
both loci (Table 7). A separate statistical evaluation of these
interactions in females and males was not possible due to
the low numbers of mice in some genotypes, but the
interaction effects were similar in both sexes (data not
shown).
Serum IL-4 concentration is influenced by one inter-
locus interaction. Lmr22 marked by D12Mit37 interacts
with Lmr5 linked to D10Mit12. The highest and lowest
level of IL-4 is observed in BALB/c and STS homozygotes,
respectively, at both loci (corr. P=2.69×10
−2). This
interaction accounts for 7.71% of variance (Table 8).
Sex differences in genetic control of lesion size, spleno-
megaly, and serum level of IgE were revealed when
analyzing the male and female F2 hybrids separately.
Influence of sex was high for skin lesions during the whole
course of infection (P<1.68×10
−5) and IgE level in serum
(P=1.41×10
−2). The impact of the Lmr loci controlling
these parameters appears to be stronger in females than in
males. However, this influence of sex was independent of
the segregating genes, as there was no significant interac-
tion between sex and any of the tested markers.
Discussion
There is extensive literature about genetic control of L.
major-induced disease (Demant et al. 1996;B e e b ee ta l .
1997; Roberts et al. 1997, 1999; Lipoldová et al. 2000;
Badalová et al. 2002;V l a d i m i r o ve ta l .2003; Havelková
et al. 2006), but until now there are no reports on the
genetics of parasite elimination. However, the genetics of
host–pathogen interactions has two important parts:
genetics of infection that describes genes that participate
in the control of the spread of the infectious agent within
the host and genetics of disease development that analyzes
the immune and pathological responses of the host. We
used genetic dissection to elucidate the functional rela-
tionship between the two components of the disease. This
study represents the first genome-wide search for loci
controlling parasite elimination and dissemination after L.
major infection. Our results show that these processes
correlate only partly.
Controlling loci and their function We have detected five
loci that in the strain CcS-11 control host–parasite
interaction (Table 2,F i g .3). We have found that parasite
Table 2 Summary of Lmr loci that control response to L. major in the
strain CcS-11
Locus Chr. Marker
(position in cM)
Trait controlled
Lmr20 1 D1Mit403 (100) Parasite load in draining
LNs, serum IgE, serum
IFNγ (in interaction with
Lmr23)
Lmr21 7 D7Mit67 (63.5) Lesion development, serum
IFNγ (in interaction
with Lmr5)
Lmr5 10 D10Mit12 (56);
D10Mit46 (63)
Lesion size, parasite load in
spleen, splenomegaly,
serum IgE, serum IFNγ
(in interaction with
Lmr21), serum IL-4 (in in-
teraction with Lmr22)
Lmr22 12 D12Mit37 (1) Serum IL-4 (in interaction
with Lmr5)
Lmr23 16 D16Mit73 (8.6) Serum IFNγ (in interaction
with Lmr20)
Only the QTLs with corrected P<0.05 (genome-wide significance) are
shown.
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626 Immunogenetics (2009) 61:619–633numbers in lymph nodes and in spleen are controlled
independently: the locus Lmr20 on chromosome 1
influences parasite load in draining lymph nodes,
whereas parasite load in spleen is determined by the
locus Lmr5 on chromosome 10. Lmr20 is not involved in
regulation of skin lesion size, splenomegaly, or hepato-
megaly, but it influences systemic immunological changes:
it controls serum IgE levels in females, and it interacts
with Lmr23 on chromosome 16 in regulation of IFNγ
level in serum.
The control of spread of parasites to spleen is exercised by
another locus—Lmr5. In females, Lmr5 controls parasite
numbers in spleen and splenomegaly. This locus also
influences pathology of another organ (the skin lesions). It
h a sa ni m p a c to nt h es y s t e m i ci m m u n er e s p o n s eb y
influencing serum IgE level, and in interactions with Lmr21
on chromosome 7 and Lmr22 on chromosome 12, also serum
levels of IFNγ and IL-4, respectively. The BALB/c allele of
Lmr5 is associated with a larger parasite load, splenomegaly,
and skin lesion size as well as higher IgE levels.
Table 4 Loci controlling skin lesion development after infection with L. major in both sexes and separately in female and male F2 hybrids
between CcS-11 and BALB/c
Locus Group Marker Genotype P value Corrected P value
CC CS SS
Lmr5 Both sexes D10Mit12 79.09±1.61 (n=62) 71.46±1.03 (n=151) 59.18±1.40 (n=82) 1.16×10
−6 5.27×10
−5
D10Mit46 79.84±1.64 (n=61) 70.94±1.04 (n=151) 58.90±1.47 (n=76) 1.05×10
−6 4.83×10
−5
Females D10Mit12 79.06±2.29 (n=33) 66.16±1.58 (n=70) 52.01±1.91 (n=48) 6.34×10
−6 2.67×10
−4
D10Mit46 79.19±2.52 (n=28) 66.60±1.56 (n=73) 52.26±1.91 (n=49) 1.88×10
−5 7.28×10
−4
Males D10Mit12 79.12±2.15 (n=29) 76.03±1.29 (n=81) 69.23±1.98 (n=34) 0.147 NS
D10Mit46 80.39±2.03 (n=33) 75.00±1.32 (n=78) 70.89±2.24 (n=27) 0.207 NS
Lmr21 Both sexes D7Mit282 109.53±3.63 (n=77) 102.90±2.64 (n=140) 86.35±3.98 (n=63) 4.3×10
−3 0.0972
(suggestive)
D7Mit67 113.18±3.58 (n=79) 101.54±2.69 (n=132) 85.39±3.53 (n=77) 4.25×10
−4 0.0116
Females D7Mit282 103.20±4.92 (n=45) 93.89±3.63 (n=80) 81.06±6.57 (n=25) 0.1012 NS
D7Mit67 110.14±4.62 (n=46) 91.70±3.62 (n=71) 76.65±5.44 (n=32) 1.8×10
−3 0.0458
Males D7Mit282 109.67±5.18 (n=32) 112.75±3.79 (n=60) 98.87±4.76 (n=38) 0.0895 NS
D7Mit67 113.89±5.39 (n=33) 112.31±3.84 (n=61) 99.95±4.45 (n=45) 0.172 NS
Mean and SE values were obtained by analysis of variance. Lesion size (mm
2) exhibited normal distribution without transformation. C and S
indicate the presence of BALB/c and STS allele, respectively; n indicates number of mice. The values for Lmr5 were calculated by analysis of
covariance from all five time points (from 4 to 8 weeks of infection) as described in Materials and methods; the values for Lmr21 by analysis of
variance for week8.
Table 5 Loci controlling IgE level in L. major infected F2 hybrids between CcS-11 and BALB/c
Locus Group Marker Genotype P value Corrected
P value
Percent of
explained
variance CC CS SS
Lmr20 Both sexes D1Mit403 21.63 5.39±0.20
(n=69)
16.86 4.75±0.13
(n=157)
12.69 4.05±0.20
(n=69)
4.35×10
−5 3.07×10
−3 6.09
Females D1Mit403 19.87 5.17±0.25
(n=39)
13.25 4.15±0.18
(n=73)
10.00 3.49±0.24
(n=41)
2.36×10
−5 1.81×10
−3 11.76
Males D1Mit403 18.54 4.99±0.33
(n=30)
17.44 4.83±0.20
(n=84)
13.86 4.26±0.34
(n=28)
0.235 NS –
Lmr5 Both sexes D10Mit12 18.03 4.92±0.22
(n=62)
16.19 4.65±0.14
(n=150)
11.82 3.88±0.19
(n=81)
5.58×10
−4 3.02×10
−2 4.70
Females D10Mit12 17.25 4.81±0.28
(n=33)
13.90 4.27±0.19
(n=70)
11.49 3.81±0.24
(n=47)
2.98×10
−2 NS –
Males D10Mit12 18.38 4.97±0.33
(n=29)
18.78 5.02±0.20
(n=80)
11.92 3.90±0.30
(n=34)
8.64×10
−3 NS –
Mean and SE values were obtained by analysis of variance. In order to obtain normal distribution required for analysis of variance value of IgE in
serum (μg/ml) was transformed by natural logarithm of value to the power of 1.5. The numbers in bold give the average non-transformed values.
C and S indicate the presence of BALB/c and STS allele, respectively; n indicates number of mice.
Immunogenetics (2009) 61:619–633 627The second locus that controls development of the skin
lesions, Lmr21 on chromosome 7, is not involved in control
of parasite load in the lymph nodes nor in the spleen. Loci
Lmr22 (chromosome 12) and Lmr23 (chromosome 16)
control only systemic immune responses—serum IL-4 and
IFNγ level, respectively. They do not affect parasite load,
splenomegaly, or skin lesions.
It is important to understand that, as in any QTL study,
failure to find a linkage between a phenotype and a marker
does not rule out that such linkage may exist, although its
phenotypic effect are likely smaller than in the detected
linkages. So for a QTL, which affects several but not all
parameters of a complex disease, this indicates that it has
predominant effects on some parameters, although it might
modify to a lesser extent other parameters as well.
Most loci we describe here affect several phenotypic
traits. It is possible that some of these loci contain several
linked genes, each affecting a different trait or a different
subset of these traits. This is an important issue that needs
to be resolved by recombinational analysis, as postulation
of separate but linked loci merely on basis of a segregation
study could be erroneous because of likely confounding
random variations.
Control of parasite elimination differs between organs The
loci Lmr20 and Lmr5 control differentially parasite numb-
ers in lymph nodes and spleen, respectively, suggesting a
predominantly organ-specific control of parasite load. This
hypothesis is compatible with the mechanistic studies of
others. The enzymes inducible nitric oxide synthase and
phagocyte NADPH oxidase, which are required for the
control of L. major, display organ- and stage-specific anti-
Leishmania effects (Stenger et al. 1996; Blos et al. 2003).
Inducible nitric oxide synthase has been shown to control
resistance to parasites in skin and draining lymph nodes,
but not in spleen of resistant strain C57BL/6 (Stenger et al.
1996). On the other hand, activity of phagocyte NADPH
oxidase is essential for the clearance of L. major in the
spleen, but it is dispensable for the resolution of the acute
skin lesions and it exerted only a limited effect on the
containment of the parasites in the draining lymph node
(Blos et al. 2003). Similarly, the genes Lmr20 and Lmr5
Table 6 Interactions between loci (Lmr20 and Lmr23) that control level of IFNγ in serum in L. major infected F2 hybrids between CcS-11 and
BALB/c
Expl. var.=6.93% P=5.15×10
−4 Corr. P=2.01×10
−2
D1Mit403 (Lmr20)
D16Mit73 (Lmr23)C C C S S S
CC 14.03 1.63±0.11 (n=11) 12.05 1.58±0.06 (n=37) 7.48 1.42±0.10 (n=16)
CS 15.68 1.66±0.06 (n=35) 7.89 1.44±0.05 (n=69) 6.34 1.36±0.09 (n=20)
SS 4.36 1.21±0.11 (n=12) 6.75 1.38±0.07 (n=33) 16.95 1.68±0.10 (n=16)
Mean and SE values were obtained by analysis of variance. The linkage significant at whole genome level is given. In order to obtain normal
distribution, we used natural logarithm of (IFNγ in serum [ng/ml] to the power of 0.5) and natural logarithm (IL-4 in serum [ng/ml] to the power
of 1.1). The numbers in bold give the average non-transformed values. C and S indicate the presence of BALB/c and STS allele, respectively;
n indicates number of mice.
Table 7 Interactions between loci (Lmr21 and Lmr5) that control level of IFNγ in serum in L. major infected F2 hybrids between CcS-11 and
BALB/c
Expl. var.=7.18% P=4.96×10
−4 Corr. P=1.95×10
−2
D7Mit67 (Lmr21)
D10Mit12 (Lmr5)C C C S S S
CC 4.86 1.26±0.09 (n=18) 13.66 1.62±0.07 (n=25) 21.93 1.76±0.11 (n=11)
CS 11.81 1.57±0.06 (n=34) 8.86 1.48±0.05 (n=57) 11.71 1.57±0.07 (n=30)
SS 11.59 1.57±0.09 (n=16) 6.71 1.38±0.07 (n=30) 4.91 1.26±0.09 (n=17)
Mean and SE values were obtained by analysis of variance. The linkage significant at whole genome level is given. In order to obtain normal
distribution, we used natural logarithm of (IFNγ in serum [ng/ml] to the power of 0.5) and natural logarithm (IL-4 in serum [ng/ml] to the power
of 1.1). The numbers in bold give the average non-transformed values. C and S indicate the presence of BALB/c and STS allele, respectively;
n indicates number of mice.
628 Immunogenetics (2009) 61:619–633might operate in different pathways of parasite killing or
their function might be exerted by mediators produced by
cells that influence these pathways.
Control of cytokine levels and its relationship to organ
pathology and parasite numbers Several Lmr loci control
IFNγ levels in combination with organ or skin pathology
and parasite numbers. Different loci control different
groups of phenotypes: Lmr5—organ pathology, parasite
numbers in spleen, IFNγ level, and IL-4 levels; Lmr20—
parasite numbers in lymph nodes and IFNγ level; Lmr21—
organ pathology and IFNγ level; Lmr23—IFNγ only (For
Table 8 Interactions between loci that control level of IL-4 in serum in L. major infected F2 hybrids between CcS-11 and BALB/c
Expl. var.=7.71% P=7.04×10
−4 Corr. P=2.69×10
−2
D10Mit12 (Lmr5)
D12Mit37 (Lmr22)C C C S S S
CC 9.04 2.38±0.38 (n=6) 3.57 1.30±0.19 (n=24) 5.90 1.88±0.23 (n=17)
CS 4.57 1.58±0.20 (n=23) 7.77 2.20±0.13 (n=55) 4.15 1.48±0.21 (n=20)
SS 5.10 1.71±0.23 (n=17) 7.09 2.09±0.18 (n=26) 3.42 1.26±0.24 (n=15)
Mean and SE values were obtained by analysis of variance. The linkage significant at whole genome level is given. In order to obtain normal
distribution, we used natural logarithm of (IFNγ in serum [ng/ml] to the power of 0.5) and natural logarithm (IL-4 in serum [ng/ml] to the power
of 1.1). The numbers in bold give the average non-transformed values. C and S indicate the presence of BALB/c and STS allele, respectively;
n indicates number of mice.
Fig. 2 Effects of genotype and
sex on size of cutaneous lesion
at Lmr5 (a, b) and Lmr21 (c, d)
weeks4 to 8 after infection. The
means and standard errors of
means (error bars) for each of
the three genotypes at different
time points are given. The
numbers of mice for D10Mit12
were 151 females and 144
males; for D7Mit67 149 females
and 139 males. C and S indicate
the presence of BALB/c and
STS allele, respectively
Immunogenetics (2009) 61:619–633 629interaction of these loci see Table 2). This suggests that
pathology-controlling and/or parasite-controlling genes
Lmr5, Lmr21,a n dLmr20 might operate via pathways that
involve IFNγ. Some genes, such as Lmr22 and Lmr23,a r e
involved only in control of systemic immune response.
These observations are in agreement with our previous
detailed data on relationship of levels of IFNγ,I L - 1 2 ,T N F α,
IL-4 and IL-6, and organ pathology (Havelková et al. 2006)
that indicated that there is no simple correlation between
production of cytokines and development of disease. The
influence of individual Lmr loci on several phenotypes can
be due either to multiple effects of a single gene or these loci
may comprise two or more closely linked genes with
different effects.
Sex influence on parasite elimination, organ pathology, and
systemic disease Our data show a sex influence on parasite
numbers in secondary immune organs. Although strains
BALB/c and CcS-11 did not exhibit any sex influence on
lesion size, males of strain CcS-11 contained more parasites
in spleens than females and males of both strains had much
higher parasite load in lymph nodes. Previously, Mock and
Nacy (1988) also reported higher parasite numbers in livers
of males of BALB/cAnPt, DBA/2N, CDF1 and DBA/2J
mice intravenously injected by L. major.T h e s ed a t a
collectively suggest that some genes controlling suscepti-
bility to L. major might operate differently in the two sexes;
however, we did not find instances of significant marker–
sex interactions. Lmr20 influences IgE level in serum only
Fig. 3 Position of the loci that
control response to L. major in
strain CcS-11. The regions of
STS and BALB/c origin are
represented as dark and white,
respectively; the boundary
regions of undetermined origin
are shaded. Only the markers
defining the boundaries the
STS-derived segment and the
markers that were tested for
linkage are shown. The markers
that exhibit significant P values
(corrected for genome-wide
search) are shown in boxes. The
arrows indicate the regions of
significant linkage
630 Immunogenetics (2009) 61:619–633in females. Genes controlling infections that appear to be
sex dependent have been observed also with other
pathogens. For example, Rmp4 (resistance to mouse pox
4) controls susceptibility to ectromelia virus in female mice
only (Brownstein and Gras 1995) and Hrl (herpes resis-
tance locus) exhibits higher influence on susceptibility to
Herpes simplex virus in male than in female mice
(Lundberg et al. 2003). Sex-specific QTLs influence also
susceptibility to Theiler’s murine encephalomyelitis virus-
induced demyelination: loci Tmved7 and 8 affect male mice
only, whereas locus Tmved9 controls susceptibility only in
females. Locus Tmved6 operates both in females and males,
Table 9 Potential candidate genes for Lmr loci controlling response to L. major in strain CcS-11
Chr. Locus Marker Position in cM Potential candidate gene Position in cM
Fcer1a, Fc receptor, IgE, high affinity I,
alpha polypeptide (Lewis et al. 2004)
94.2
Fcer1g, Fc receptor, IgE, high affinity I,
gamma polypeptide (Lewis et al. 2004)
93.3
Fcgr2b, Fc receptor, IgG, low affinity Iib
(Padigel and Farrell 2005; Woelbing et al. 2006)
92.3
Cluster of IFN activated genes (Ifi201, Ifi202a,
Ifi203, Ifi204, Ifi505) (Blos et al. 2003)
95.2–95.3
1 Lmr20 D1Mit403 100 Tgfb2 transforming growth factor, beta 2
(Padigel and Farrell 2005)
101.5
7 Lmr21 D7Mit67 63.5 Il4r, IL-4 receptor alpha chain (CD124)
(Gessner et al. 1994)
62.0
10 Lmr5 D10Mit12 56.0
D10Mit46 63.0 Ifng, interferon gamma (Nacy et al. 1985) 67.0
12 Lmr22 D12Mit37 1.0 Adam17 (a disintegrin and metalloproteinase domain 17)
(Moss et al. 1997)
3.0
16 Lmr23 D16Mit73 8.6 Two clusters of genes that affect B-cell development
(Igl-C5, Igll1, Vpreb1, Vpreb2; Igl-C1, Igl-C2, Igl-C3,
Igl-V1, Igl-V2, Igl1-r) (Hoerauf et al. 1996; DeKrey et al. 2003)
9.8
13.0
Table 10 Co-mapping with loci controlling other infections and other possibly related QTLs
Chr. Locus Marker Position in cM Co-localization with other possibly related QTLs Position in cM
Tir3c, trypanosomiasis infection response 3c
(Iraqi et al. 2000)
93.0
Ssta2, susceptibility to Salmonella typhimurium
antigens 2 (Trezena et al. 2002)
95.8
1 Lmr20 D1Mit403 100 Bbaa12, Borrelia burgdorferi-associated arthritis 12
(Roper et al. 2001)
96.0
berr1, Berghei resistance locus 1 (Bagot et al. 2002) 102.0
Tria4, T-cell receptor induced activation 4
(Havelková et al. 1999)
46.0
Heal6, wound healing/regeneration 6
(Mcbrearty et al. 1998)
52.4
Tsiq1, T-cell secretion of IL-4 QTL1 (Choi et al. 2005) 59.0
7 Lmr21 D7Mit67 63.5 Dice2, determination of interleukin 4 commitment 2
(Bix et al. 1998)
63.5
12 Lmr22 D12Mit37 1.0 Cinda2, cytokine-induced activation (Krulová et al. 1997) 1.0
Cd4ts5, CD4 T-cell subset 5 (Jackson et al. 2003) 6.0
16 Lmr23 D16Mit73 8.6 Dice1, determination of interleukin 4 commitment 1
(Bix et al. 1998; Baguet et al. 2004)
8.0
Immunogenetics (2009) 61:619–633 631but it has an opposite effect on disease susceptibility in
males and females (Butterfield et al. 2003).
Potential candidate genes The Lmr loci described here are
mapped with a precision of 6–30 cM. The regions of the
most probable linkage (estimated as the distance of markers
that exhibit no significant linkage but are the closest to the
markers with linkage) were between 4 and 19 cM long
(Fig. 3), which is customary for the newly detected loci
(Flint et al. 2005). These broad loci contain each several
genes that have been shown previously to influence
infection with L. major or that also influence responses to
other pathogens as well as some immunological traits (for
references, see Tables 9 and 10); however, the effects of
many of Lmr loci might be caused by genes that are
presently not suspected candidates. Presently, we are
producing mice with recombinant haplotypes that carry
each Lmr locus in a very short segment on chromosome.
The testing of these strains will restrict the present number
of the candidate genes to the most likely ones.
In summary, we show that L. major parasite load and
disease manifestations are controlled by distinct sets of
genes. Other genes also determine important immunological
and pathological phenotypes of infected mice, but they do
not appreciably affect parasite burden. By indicating which
of the loci that control immune response and/or organ
pathology are involved also in elimination or suppression of
the parasite and which are not, these results represent an
important step in a progress towards integration of genetic
data and results from functional immunological studies.
An important corollary of these findings is that in
humans there also likely exist polymorphic genes that
control numbers of parasites and their organ distribution as
well as other genes that affect some components of immune
response and/or development or organ pathology but not
parasite load. These polymorphisms will result in important
individual differences in the “functional architecture” of the
disease, its progression being in different individuals driven
by different pathways. An apparently identical clinical
phenotype in different individuals therefore can result from
different functional pathways, and hence could differ in
prognosis and response to therapy.
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